High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.

Tinubu has congratulated ARISE NEWS DMD Bayo Awosemo on his 70th birthday, commending him for enhancing Nigeria’s image ...

Entrada Therapeutics has secured authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to ...

Robert Davidson is the first UK patient recruited to a new medical trial looking to support children with heart failure ...

Pharmaceuticals announced positive top-line results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel ...

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

NASHVILLE, Tenn. - Cumberland Pharmaceuticals Inc. (NASDAQ: NASDAQ:CPIX), a specialty pharmaceutical company with a market ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares began Tuesday sharply higher. Cumberland, a specialty pharmaceutical company with development efforts focused on new products for rare diseases, ...

Thursday is the deadline for federal employees to accept President Donald Trump’s so-called buyout offer, something open to ...

Union Bank PLC recently appointed Mohammad Iqbal to the post of deputy managing director (DMD)..Prior to this role at the 4th ...